Pacira BioSciences, Inc. Faces Securities Fraud Class Action Lawsuit: Learn About Your Rights and Options Before March 14, 2025 – Contact The Gross Law Firm

Important Notice for Pacira BioSciences, Inc. Shareholders The Gross Law Firm, a leading shareholder rights law firm, announces that a class action lawsuit has been filed against Pacira BioSciences, Inc. (PCRX) in the United States District Court for the Southern District of New York. The lawsuit alleges that certain statements made by the Company during…

Read More

Discover the Exciting New Developments at Braxia Scientific: A Peek into Their Latest Updates

Braxia Scientific’s Latest Update: Failure to File Cease Trade Order and CSE Listing Toronto, Ontario, February 19, 2025 – In an update released recently, Braxia Scientific Corp. (BRAX, BRAXF, 4960) shared some important information regarding their current status with the Ontario Securities Commission (OSC). Let’s delve deeper into this situation. Background On August 6, 2024,…

Read More